# US 2004/0082500 A1 · Composition and method for reducing the risk or progression of cardiovascular, glaucoma and tardive dyskinesia diseases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0082500 A1
- Document ID: US20040082500A1
- Status: Published application
- Kind: A1
- Application number: 10/601,942
- Filed: 2003-06-23
- Published: 2004-04-29
- Earliest claimed: 2001-04-30
- Inventors: Robert E. Sosnowski; Philip C. Lang
- Web page: https://patentgrep.com/patent/US20040082500A1

## CPC

- A61K 31/015: carbocyclic
- A61K 31/525: Isoalloxazines, e.g. riboflavins, vitamin B2
- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A61K 36/16: Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
- A61K 36/45: Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
- A61K 36/67: Piperaceae (Pepper family), e.g. Jamaican pepper or kava
- A61K 36/8962: Allium, e.g. garden onion, leek, garlic or chives
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Elevated levels of homocysteine have been implicated as an important risk factor for cardiovascular and other diseases. A composition for decreasing levels of plasma homocysteine and a method for administering the composition are provided the composition containing dextromethorphan (DM), folic acid and vitamins B6 and B12. The composition provides a synergistic therapeutic effect so that lower amounts of the above ingredients may be employed to minimize any undesirable side effects caused by the use of high levels of a component such as DM. Preferred compositions for cardiovascular diseases further include lecithin, vitamin E, beta-carotene, procyanidins/flavonoids, trimethylglycine, garlic oil and minerals. Other compositions for treating glaucoma include bilberry, bioflavonoids and beta-carotene and for treating tardive dyskinesia include an antioxidant such as grape seed extract and pine bark extract, lecithin and oligomeric proanthocyanidins. The compositions may be administered using any suitable means such as orally or intravenous.

## Claims

### Claim 1

A composition for reducing the risk or progression of cardiovascular disease comprising:
dextromethorphan;
folic acid or folate;
vitamin B6; and
vitamin B12.

### Claim 2 (depends on 1)

The composition of claim 1 wherein the composition includes lecithin and vitamin E.

### Claim 3 (depends on 2)

The composition of claim 2 wherein the composition includes beta-carotene.

### Claim 4 (depends on 3)

The composition of claim 3 wherein the composition includes a compound selected from the group consisting of procyanidins, flavonoids, oligomeric proanthocyanidins and mixtures thereof.

### Claim 5 (depends on 4)

The composition of claim 4 wherein the composition includes trimethylglycine and ginkgo biloba.

### Claim 6 (depends on 5)

The composition of claim 5 wherein the composition includes garlic oil and minerals.

### Claim 7 (depends on 1)

A method of reducing the risk or progression of cardiovascular disease comprising administering to a person in need thereof the composition of claim 1.

### Claim 8 (depends on 2)

A method of reducing the risk or progression of cardiovascular disease comprising administering to a person in need thereof the composition of claim 2.

### Claim 9 (depends on 3)

A method of reducing the risk or progression of cardiovascular disease comprising administering to a person in need thereof the composition of claim 3.

### Claim 10 (depends on 4)

A method of reducing the risk or progression of cardiovascular disease comprising administering to a person in need thereof the composition of claim 4.

### Claim 11 (depends on 5)

A method of reducing the risk or progression of cardiovascular disease comprising administering to a person in need thereof the composition of claim 5.

### Claim 12 (depends on 6)

A method of reducing the risk or progression of cardiovascular disease comprising administering to a person in need thereof the composition of claim 6.

### Claim 13

A composition for reducing the risk or progression of glaucoma comprising:
dextromethorphan;
folic acid or folate;
vitamin B6; and
vitamin B12;
bilberry;
bioflavonoids; and
beta-carotene

### Claim 14 (depends on 13)

The composition of claim 13 further including oligomeric proanthocyanidins.

### Claim 15 (depends on 14)

The composition of claim 14 further including vinpocetine.

### Claim 16 (depends on 15)

The composition of claim 15 further including omega-3-oils.

### Claim 17 (depends on 13)

A method for reducing the risk or progression of glaucoma comprising administering to a person in need thereof the composition of claim 13.

### Claim 18 (depends on 14)

A method for reducing the risk or progression of glaucoma comprising administering to a person in need thereof the composition of claim 14.

### Claim 19 (depends on 15)

A method for reducing the risk or progression of glaucoma comprising administering to a person in need thereof the composition of claim 15.

### Claim 20

A composition for reducing the risk or progression of tardive dyskinesia disease comprising:
dextromethorphan;
folic acid or folate;
vitamin B6; and
vitamin B12;
lecithin;
an antioxidant; and
oligomeric proanthocyanidins.

### Claim 21 (depends on 20)

The composition of claim 20 further including pantothenic acid.

### Claim 22 (depends on 21)

The composition of claim 21 further including kava.

### Claim 23 (depends on 22)

The composition of claim 22 further including omega-3-oils.

### Claim 24 (depends on 23)

The composition of claim 23 further including vitamin B3.

### Claim 25 (depends on 20)

A method of reducing the risk of progression of tardive dyskinesia disease comprising administering to a person in need thereof the composition of claim 20.

### Claim 26 (depends on 21)

A method of reducing the risk of progression of tardive dyskinesia disease comprising administering to a person in need thereof the composition of claim 21.

### Claim 27 (depends on 22)

A method of reducing the risk of progression of tardive dyskinesia disease comprising administering to a person in need thereof the composition of claim 22.

### Claim 28 (depends on 23)

A method of reducing the risk of progression of tardive dyskinesia disease comprising administering to a person in need thereof the composition of claim 23.

### Claim 29 (depends on 24)

A method of reducing the risk of progression of tardive dyskinesia disease comprising administering to a person in need thereof the composition of claim 24.
